EBOS Group (ASX:EBO, NZE:EBO) reported Wednesday fiscal half-year diluted earnings of AU$0.569 per share, down from AU$0.71 per share a year earlier.
Analysts polled by FactSet expected EPS of AU$0.71.
Revenue for the six months ended Dec. 31, 2024, was AU$5.99 billion, down 9% from AU$6.58 billion a year earlier. Analysts surveyed by FactSet expected AU$5.73 billion in sales revenue.
The healthcare products distributor maintained its guidance of underlying earnings before interest, taxes, depreciation, and amortization of between AU$575 million and AU$600 million for the fiscal year, up 5% to 10% year on year.
The board declared a dividend of NZ$0.57 per share, unchanged from the previously reported period, payable on March 21 to shareholders of record as of Feb. 28.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。